ASCO announces its own COVID-19 and cancer registryApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Cancer prevalence among COVID-19 patients may be higher than previously reportedApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Home-based chemo skyrockets at one U.S. centerApril 10, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Managing pediatric heme/onc departments during the pandemicApril 9, 2020PediatricsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020PediatricsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Maintaining cancer care in the face of COVID-19April 1, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatrics
Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Disruptions in cancer care in the era of COVID-19March 20, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
FDA approves new drug for relapsed/refractory multiple myelomaMarch 2, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
FDA: Cell phones still look safeFebruary 11, 2020Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
CRISPR-engineered T cells may be safe for cancer, but do they work?February 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Global project reveals cancer’s genomic playbookFebruary 5, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphomaFebruary 1, 2020Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
